Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 571-581

  Kubo, Masahide ^a   Czuwara Ladykowska, Joanna ^a   Moussa, Omar ^b   Markiewicz, Margaret ^a   Smith, Edwin ^a   Silver, Richard M ^a   Jablonska, Stefania ^c   Blaszczyk, Maria ^c   Watson, Dennis K ^b   Trojanowska, Maria ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FLI1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; TRANSCRIPTION REGULATION; VALIDATION PROCESS;

EID: 0042846026     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63685-1     Document Type: Article

References (44)

1. LeRoy EC: The connective tissue in scleroderma. Coll Relat Res 1981, 1:301-308
2. Trojanowska M, LeRoy EC, Eckes B, Krieg T: Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med 1998, 76:266-274
3. Kahari VM: Activation of dermal connective tissue in scleroderma. Ann Med 1993, 25:511-518
4. Fleischmajer R, Gay S, Meigel WN, Perlish JS: Collagen in the cellular and fibrotic stages of scleroderma. Arthritis Rheum 1978, 21:418-428
5. Ohtsuka T, Koibuchi N, Sakai H, Yamakage A, Yamazaki S: Quantitative analysis of alpha 1(I) and alpha 1(III) procollagen mRNA expression in systemic sclerosis skin tissue - an in situ hybridization study. Arch Dermatol Res 1999, 291:575-582
6. Peltonen J, Kahari L, Uitto J, Jimenez SA: Increased expression of type VI collagen genes in systemic sclerosis Arthritis Rheum 1990, 33:1829-1835
7. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Uitto J: Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest 1994, 93:1709-1715
8. Fisher GJ, Datta S, Wang Z, Li XY, Quan T, Chung JH, Kang S, Voorhees JJ: c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 2000, 106:663-670
9. Widom RL: Regulation of matrix biosynthesis and degradation in systemic sclerosis. Curr Opin Rheumatol 2000, 12:534-539
10. Trojanowska M: Molecular aspects of scleroderma. Front Biosci 2002, 7:D608-D618
11. Ghosh AK: Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood) 2002, 227:301-314
12. Kikuchi K, Hartl CW, Smith EA, LeRoy EC, Trojanowska M: Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. Biochem Biophys Res Commun 1992, 187:45-50
13. Hitraya EG, Varga J, Artlett CM, Jimenez SA: Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum 1998, 41:2048-2058
14. Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA: CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum 2000, 43:2219-2229
15. Tamaki T, Ohnishi K, Hartl C, LeRoy EC, Trojanowska M: Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the alpha 2(I) collagen gene in human fibroblasts. J Biol Chem 1995, 270:4299-4304
16. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M: Transcriptional regulation of the human alpha2(I) collagen gene. Combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem 1996, 271:26717-26723
17. Ihn H, Tamaki K: Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene. Arthritis Rheum 2000, 43:2240-2247
18. Varga J: Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002, 46:1703-1713
19. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, ten Dijke P, White B, Wigley FM, Goldschmidt-Clermont PJ: Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002, 99:3908-3913
20. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M: Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 2001, 276: 20839-20848
21. Truong AH, Ben-David Y: The role of Fli-1 in normal cell function and malignant transformation. Oncogene 2000, 19:6482-6489
22. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK: Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 2000, 20:5643-5652
23. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A: Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000, 13:167-177
24. Brown LA, Rodaway AR, Schilling TF, Jowett T, Ingham PW, Patient RK, Sharrocks AD: Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech Dev 2000, 90:237-252
25. Wasylyk B, Hagman J, Gutierrez-Hartmann A: Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 1998, 23:213-216
26. Trojanowska M: Ets factors and regulation of the extracellular matrix. Oncogene 2000, 19:6464-6471
27. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M, Wigley FM, Ingenito F, Weisman M, White B, Martin RW, McCloskey D, Moreland LW, Mayes M, Lally EV, Unanue M, Collier DH, Weiner S, Weinstein A, Medsger Jr TA, Andrews B, Dixon M, Furst DE: Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993, 20:1892-1896
28. Kubo M, Ihn H, Yamane K, Tamaki K: Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 2001, 44:731-734
29. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95:2509-2514
30. Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M: Etsl is an effector of the transforming growth factor Beta (tgf-beta) signaling pathway and an antagonist of the profibrotic effects of tgf-beta. J Biol Chem 2002, 277:20399-20408
31. Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M: Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 1999, 18:7755-7764
32. Kivirikko KI, Myllyharju J: Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol 1998, 16:357-368
33. Nagata K: Expression and function of heat shock protein 47: a collagen-specific molecular chaperone in the endoplasmic reticulum. Matrix Biol 1998, 16:379-386
34. Kouba DJ, Chung KY, Nishiyama T, Vindevoghel L, Kon A, Klement JF, Uitto J, Mauviel A: Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol 1999, 162:4226-4234
35. Strehlow D, Jelaska A, Strehlow K, Korn JH: A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma. J Clin Invest 1999, 103:1179-1190
36. Scharffetter K, Lankat-Buttgereit B, Krieg T: Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest 1988, 18:9-17
37. Claman HN, Giorno RC, Seibold JR: Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin." Arthritis Rheum 1991, 34:1495-1501
38. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992, 166:255-263
39. Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MI: Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy. Br J Dermatol 1992, 126:561-568
40. Postiglione L, Montagnani S, Riccio A, Montuori N, Sciorio S, Ladogana P, Spigna GD, Castaldo C, Rossi G: Enhanced expression of the receptor for granulocyte macrophage colony stimulating factor on dermal fibroblasts from scleroderma patients. J Rheumatol 2002, 29:94-101
41. Majewski S, Hunzelmann N, Johnson JP, Jung C, Mauch C, Ziegler-Heitbrock HW, Riethmuller G, Krieg T: Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol 1991, 97:667-671
42. Koch AE, Kronfeld-Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, Strieter RM, Kunkel SL, Massa MC, Barr WG, Jimenez HA: In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993, 61:239-246
43. Gruschwitz MS, Vieth G: Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage. Arthritis Rheum 1997, 40:540-550
44. Jimenez SA: Alterations in the regulation of expression of the a1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol 2000, 21:397-414